Atai Life Sciences Price to Free Cash Flow Ratio 2020-2024 | ATAI
Atai Life Sciences Price to Free Cash Flow Ratio Historical Data | |||
---|---|---|---|
Date | Stock Price | TTM FCF per Share | Price to FCF Ratio |
2024-09-26 | 1.19 | 0.00 | |
2024-06-30 | 1.33 | $-0.49 | 0.00 |
2024-03-31 | 1.97 | $-0.54 | 0.00 |
2023-12-31 | 1.41 | $-0.53 | 0.00 |
2023-09-30 | 1.29 | $-0.55 | 0.00 |
2023-06-30 | 1.72 | $-0.66 | 0.00 |
2023-03-31 | 1.81 | $-0.66 | 0.00 |
2022-12-31 | 2.66 | $-0.68 | 0.00 |
2022-09-30 | 3.31 | $-0.65 | 0.00 |
2022-06-30 | 3.64 | $-0.65 | 0.00 |
2022-03-31 | 5.09 | $-0.62 | 0.00 |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical - Outpatient & Home Care | $0.196B | $0.000B |
atai Life Sciences B.V. is a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders. atai Life Sciences B.V. is based in BERLIN. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Fresenius SE (FSNUY) | Germany | $21.044B | 12.73 |
Quest Diagnostics (DGX) | United States | $17.232B | 17.67 |
DaVita (DVA) | United States | $13.682B | 16.83 |
Encompass Health (EHC) | United States | $9.661B | 23.76 |
Chemed (CHE) | United States | $9.016B | 27.72 |
Elanco Animal Health (ELAN) | United States | $7.079B | 15.91 |
Option Care Health (OPCH) | United States | $5.374B | 26.40 |
RadNet (RDNT) | United States | $5.127B | 121.63 |
Amedisys (AMED) | United States | $3.164B | 22.63 |
Astrana Health (ASTH) | United States | $2.775B | 39.26 |
LifeStance Health (LFST) | United States | $2.655B | 0.00 |
Addus HomeCare (ADUS) | United States | $2.370B | 28.78 |
U.S Physical Therapy (USPH) | United States | $1.272B | 34.44 |
Pennant (PNTG) | United States | $1.039B | 49.84 |
Aveanna Healthcare Holdings (AVAH) | United States | $0.999B | 0.00 |
Daxor (DXR) | United States | $0.043B | 0.00 |
ATI Physical Therapy (ATIP) | United States | $0.027B | 0.00 |
MEDIROM Healthcare Technologies (MRM) | Japan | $0.015B | 0.00 |
Psychemedics (PMD) | United States | $0.014B | 0.00 |
Ontrak (OTRK) | United States | $0.008B | 0.00 |
Novo Integrated Sciences (NVOS) | United States | $0.006B | 0.00 |
IMAC Holdings (BACK) | United States | $0.001B | 0.00 |